Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 5 clinical trials
Fusion or no Fusion After Decompression of the Spinal Cord in Patients With Degenerative Cervical Myelopathy (MyRanC)

Background Degenerative cervical myelopathy (DCM) is characterized by neck pain, neck stiffness, weakness, paresthesia, sphincter disturbance and balance disorder. The mean age for symptoms is 64 years and more men than women, 2.7:1, are affected. The most common level is C5-C6. DCM is the predominant cause of spinal cord dysfunction …

  • 12 May, 2022
Adaptix RCT Evaluating Adaptix™ Versus PEEK Cages

The purpose of this randomized controlled trial is to assess and compare radiographic and clinical outcomes in patients who are to undergo combined interbody/posterolateral lumbar fusion procedures, supplemented with pedicle screw instrumentation, using one of the following interbody cages; the Medtronic Adaptix™ cage with roughened micro and nano-textured titanium surfaces …

  • 23 Mar, 2022
  • 1 location
Determination of the Effectiveness of Certain Physical Methods in the Treatment of Knee Osteoarthritis

Osteoarthritis (OA) is a chronic joint disease that involves the entire joint, causing cartilage damage, bone remodeling, osteophyte formation and loss of normal joint function. Knee OA is one

knee pain
treatment of knee
  • 07 May, 2021
  • 1 location
Comparison of Soft Tissue Techniques on Hamstring Flexibility Knee Osteoarthritis

The aim of this research is to compare the effects of Graston Technique, active release technique and PNF stretching on hamstring flexibility in Patients with Knee Osteoarthritis. Randomized controlled trials done at Riphah International University, Islamabad.. The sample size was 45. The subjects were divided in three groups, 15 subjects …

  • 22 Dec, 2021
  • 1 location
A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS

The selective cox-2 inhibitor has been widely used in the treatment of Ankylosing spondylitis (AS). The Imrecoxib is a new cox-2 inhibitor. But the treatment strategy has not been decided yet. To determine which is better in treating AS in the methods between on-demand treatment and continuous treatment. To solve …

sedimentation rate
cox-2 inhibitor
  • 24 Jan, 2021
  • 1 location